8,655 Studies Reviewed. 86.9% Found Biological Effects. The Evidence is Clear.
Shield Your Body
Cancer & Tumors

Long-term radiofrequency electromagnetic fields exposure attenuates cognitive dysfunction in 5×FAD mice by regulating microglial function

Bioeffects Seen

Son Y, Park H-J, Jeong YJ, Choi H-D, Kim N, Lee H-J · 2023

Share:

Long-term RF-EMF exposure demonstrated a potential therapeutic effect on Alzheimer's-related cognitive decline in this mouse model through suppression of microglial proliferation and pro-inflammatory gene expression.

Plain English Summary

Summary written for general audiences

This study examined whether long-term exposure to radiofrequency electromagnetic fields (1950 MHz, 5 W/kg for 6 months) could reduce cognitive dysfunction in 5×FAD mice with Alzheimer's disease by regulating microglial function. The researchers found that RF-EMF exposure ameliorated cognitive impairment and amyloid-β deposition while reducing microglial activation markers and genes related to microgliosis and pro-inflammatory responses, with effects similar to those of a CSF1R inhibitor.

Why This Matters

This finding contrasts with typical EMF safety concerns and suggests a possible neuroprotective mechanism in this specific disease model. However, the study was conducted in transgenic mice with severe Alzheimer's pathology, and generalization to human populations or non-pathological conditions requires further investigation.

Exposure Information

Specific exposure levels were not quantified in this study.

Cite This Study
Son Y, Park H-J, Jeong YJ, Choi H-D, Kim N, Lee H-J (2023). Long-term radiofrequency electromagnetic fields exposure attenuates cognitive dysfunction in 5×FAD mice by regulating microglial function.
Show BibTeX
@article{son_y_park_h_j_jeong_yj_choi_h_d_kim_n_lee_h_j_ce3035,
  author = {Son Y and Park H-J and Jeong YJ and Choi H-D and Kim N and Lee H-J},
  title = {Long-term radiofrequency electromagnetic fields exposure attenuates cognitive dysfunction in 5×FAD mice by regulating microglial function},
  year = {2023},
  
  
}
PubMed: 37282482

Quick Questions About This Study

The study found genetic risk variants had stronger associations with lung cancer in people who never smoked compared to smokers. This suggests that in the absence of tobacco's overwhelming cancer-causing effects, genetic susceptibility and other environmental factors become more influential in cancer development.
Researchers identified 12 novel genetic variants associated with lung adenocarcinoma susceptibility, bringing the total known variants to 28 across 25 independent genetic locations. These discoveries help explain more of the inherited risk for this common cancer type.
Yes, most genetic risk variants found in East Asian populations showed no evidence of association in European populations. This highlights the importance of conducting genetic studies across diverse ancestries, as cancer susceptibility patterns can vary significantly between ethnic groups.
54.5% of the study participants were never-smokers, representing over 93,000 people. This large proportion of never-smokers was crucial for identifying how genetic factors influence lung cancer risk independent of tobacco use, revealing stronger genetic effects in this population.
The study identified FADS1 at chromosome location 11q12 and ELF5 at 11p13 as novel candidate genes for lung adenocarcinoma susceptibility. These genes were discovered through advanced analysis combining genetic associations with gene expression data from lung tissue samples.